Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing capsule plus oseltamivir for influenza with Heat-Toxin Attacking Lung Syndrome
ChiCTR2400081834Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- Mar 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tanreqing in influenza (2 arms), sponsored by Shuguang Hospital. Primary endpoint: Time to fever resolution. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
tanreqing
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2400081834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081834.